Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
AIDS Research and Human Retroviruses|May 18, 2019
Suppression of Active HIV-1 Infection in CD34<sup>+</sup> Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting DrugsOlga S Latinovic, Lauren M Neal, Yutaka Tagaya, et al.Magnetic Resonance in Medicine|October 3, 2003
Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiographyHisataka Kobayashi, Satomi Kawamoto, Peter L Choyke, et al.Current HIV Research|September 11, 2015
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and TreatmentOlga S Latinovic, Jian Zhang, Yutaka Tagaya, et al.Journal of the National Cancer Institute|May 6, 2004
Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agentHisataka Kobayashi, Satomi Kawamoto, Yoshio Sakai, et al.Scientific Reports|December 23, 2022
Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasmaSaini Setua, Kiruphagaran Thangaraju, Monika Dzieciatkowska, et al.Blood|June 23, 2023
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemiaJonathan E Brammer, Karen Ballen, Lubomir Sokol, et al.Proceedings of the National Academy of Sciences of the United States of America|December 9, 2008
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cellsMarta Catalfamo, Michele Di Mascio, Zonghui Hu, et al.Journal of Clinical Pharmacology|August 30, 2019
Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of CytokinesPaul A Frohna, Anoshie Ratnayake, Nick Doerr, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Interleukin-2-dependent mechanisms of tolerance and immunity in vivoPaul A Antony, Chrystal M Paulos, Mojgan Ahmadzadeh, et al.Blood|November 26, 2010
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSPWei Ju, Meili Zhang, Jian-kang Jiang, et al.Pageof 5